October 8, 2025 Newswires

Findings on Managed Care Reported by Researchers at Cardiovascular Research Foundation (Trends and Late Outcomes in Elderly Patients Undergoing Mitral Valve Interventions in the United States): Managed Care

Insurance Daily News

2025 OCT 08 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- Data detailed on Managed Care have been presented. According to news reporting out of New York City, New York, by NewsRx editors, research stated, “Mitral valve intervention improves clinical outcomes in selected patients with severe mitral regurgitation; less is known about the use trends and long-term outcomes of different mitral intervention strategies in real-world patients. The aim of this study was to describe use trends in mitral valve intervention and identify factors contributing to 5-year mortality in elderly patients.”

Our news journalists obtained a quote from the research from Cardiovascular Research Foundation, “The fee-for-service Centers for Medicare and Medicaid Services claims database was used to identify patients 65 years of age hospitalized for surgical or transcatheter mitral valve intervention between January 1, 2017, and December 31, 2022. The primary outcome was 5-year mortality. There were 172,478 mitral valve interventions identified over the 5-year period. The number of mitral valve interventions, indexed per 100,000 Medicare Part A beneficiaries, increased by 9.2% over this period. The incidence of surgery declined by 15.7% whereas transcatheter edge-to-edge repair (M-TEER) increased by 94.8% and transcatheter mitral valve replacement (TMVR) increased by 100%. In-hospital mortality rates were 6.9% for surgery, 4.0% for TMVR, and 1.5% for M-TEER. Five-year mortality was 39.5% after surgery, 55.1% after TMVR, and 61.9% after M-TEER. Among patients at low frailty risk, 5-year mortality rates were 24.4%, 45.8%, and 52.2% for surgery, TMVR, and M-TEER, respectively; among patients at intermediate frailty risk, they were 44.8%, 62.2%, and 70.7%, respectively; among those at high frailty risk, they were 57.8%, 74.2%, and 80.6%, respectively. Quartiles of social vulnerability were incrementally associated with higher mortality. Mitral valve interventions in elderly patients are increasing over time, driven by transcatheter therapies.”

According to the news editors, the research concluded: “Five-year mortality varied by type of intervention and was significantly influenced by frailty and social vulnerability.”

This research has been peer-reviewed.

For more information on this research see: Trends and Late Outcomes in Elderly Patients Undergoing Mitral Valve Interventions in the United States. JACC, 2025;18(18):2241-2252. JACC can be contacted at: Elsevier Science Inc, Ste 800, 230 Park Ave, New York, NY 10169, USA. (Elsevier - www.elsevier.com; JACC - http://www.journals.elsevier.com/jacc/)

Our news journalists report that additional information may be obtained by contacting David J. Cohen, Cardiovascular Research Foundation, New York, New York, United States. Additional authors for this research include Harun Kundi, Martin B. Leon, Afek Kodesh, Alexandra Popma, Philipp von Stein, Bjorn Redfors, Lauren S. Ranard, Maria C. Alu, Julia B. Thompson, Jennifer von Stein, Juan F. Granada and Jeffrey J. Popma.